Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Clinical Trial of Adjuvant Chemotherapy vs Chemoimmunotherapy for Stage IB-IIIA Completely Resected Non-small Cell Lung Cancer (NSCLC) Patients.

NCT04564157 is registered in ClinicalTrials.gov with Fundación GECP as lead sponsor.

NCT NCT04564157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04564157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Clinical Trial of Adjuvant Chemotherapy vs Chemoimmunotherapy for Stage IB-IIIA Completely Resected Non-small Cell Lung Cancer (NSCLC) Patients.
Lead sponsor
Fundación GECP
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 13, 2021
Completion date
April 1, 2031
Enrollment
210 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant chemotherapy, non-small cell lung cancer